Therapy-related acute promyelocytic leukemia: a systematic review. - Wikidata - wikimedia - TriplyDB

Therapy-related acute promyelocytic leukemia: a systematic review.

Therapy-related acute promyelocytic leukemia: a systematic review.

http://www.wikidata.org/entity/Q34351253

about

Global characteristics of childhood acute promyelocytic leukemia.CD34(+) therapy-related acute promyelocytic leukemia in a patient previously treated for breast cancer.Topoisomerase II and leukemia.Expression of RKIP in chronic myelogenous leukemia K562 cell and inhibits cell proliferation by regulating the ERK/MAPK pathway.Survival of de novo and secondary acute promyelocytic leukemia: a propensity-matched analysis of the SEER database.Producing irreversible topoisomerase II-mediated DNA breaks by site-specific Pt(II)-methionine coordination chemistry.Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group.

P2860

Q35231673-024FF135-0F48-435F-BD32-6DD1C50B04DB Q37044055-59A03822-21A4-494F-9FAC-6F814BAB5AAC Q37652882-E7C62B11-9FD2-4A68-AEBD-2B4E125AA56D Q39161075-50EFB6C0-13E4-4887-BA1F-889CA2661247 Q41662169-B7723EA8-7CD8-4FAC-B58A-D9051929A44D Q47699480-EF34BDE7-9443-495F-B9A4-9018D83F1909 Q53554112-956818D4-AA48-42D1-A22A-8EA161F5795F

P2860

Therapy-related acute promyelocytic leukemia: a systematic review.

http://www.wikidata.org/entity/Q34351253

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Therapy-related acute promyelocytic leukemia: a systematic review.

@ast

Therapy-related acute promyelocytic leukemia: a systematic review.

@en

Therapy-related acute promyelocytic leukemia: a systematic review.

@nl

type

label

Therapy-related acute promyelocytic leukemia: a systematic review.

@ast

Therapy-related acute promyelocytic leukemia: a systematic review.

@en

Therapy-related acute promyelocytic leukemia: a systematic review.

@nl

prefLabel

Therapy-related acute promyelocytic leukemia: a systematic review.

@ast

Therapy-related acute promyelocytic leukemia: a systematic review.

@en

Therapy-related acute promyelocytic leukemia: a systematic review.

@nl

P1433

Q34351253-E7DC87F7-DBD2-4BDD-A473-6B00D1BDA609

P1476

Q34351253-DE8C7DF4-07B1-4790-8318-B6C53C45C1C0

P2093

Q34351253-BCE92635-F1B4-428D-A175-7FED27B351D4

Q34351253-F1404A58-E709-420E-85B5-FED07D90E61D

P2860

Q34351253-044B7BF6-D9D8-4CDB-A36D-93500F4C00C5

Q34351253-066A6868-F290-4A28-B2DF-425D0F83499B

Q34351253-08DB4DE5-20C8-44D8-B641-6A18647B3E70

Q34351253-0EEEED35-BE46-414D-8500-C29C95A86D7F

Q34351253-0F73C5F2-B8EC-4396-89CB-B1E8EF36D5D7

Q34351253-14135A16-F259-4972-AC1F-A570E7A4D409

Q34351253-19B6B3D9-23EA-4659-A2D6-126D3F7FA79C

Q34351253-2719A421-50C9-4ED7-8E28-CA7D9B96379C

Q34351253-2C1AA722-D3B0-46D4-86EF-A138FE2FEEE2

Q34351253-30A1F5E6-C729-4FC6-8C03-84F95F763DE7

P2888

Q34351253-038420D6-9AD4-4859-808D-94ACCCBBA277

P304

Q34351253-2B541F18-DFEA-4B0F-B1F9-31D0425D83DB

P31

Q34351253-FF86C2A4-F6A7-4AD8-A44B-02122C1B96F0

P356

Q34351253-E69077FB-EDC0-4641-8E56-880C35F4A0EF

P433

Q34351253-80CE97D7-2A7F-4382-8014-3CEF62DB1EC2

P478

Q34351253-3C3472E7-07CA-4E93-8D9B-80E2BB723FE9

P577

Q34351253-9357B4A3-1651-4D45-9905-B6F728DF82E5

P6179

Q34351253-D56C99C0-9FF6-43FC-B6D3-C8CBDC2DC67B

P698

Q34351253-CCE1A252-5FAC-467C-9ED7-89629E69E4D0

P921

Q34351253-2C875B7B-3FA4-4D05-8EB4-5446C7C25804

P356

S12032-013-0625-5

P1433

Medical Oncology

P1476

Therapy-related acute promyelocytic leukemia: a systematic review.

@en

P2093

Armin Rashidi

http://www.w3.org/2001/XMLSchema#string

Stephen I Fisher

http://www.w3.org/2001/XMLSchema#string

P2860

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients.

Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia

Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes.

Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis

Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy.

All-trans retinoic acid and late relapses in acute promyelocytic leukemia: very long-term follow-up of the North American Intergroup Study I0129.

Biology and therapy of secondary leukaemias.

Leukemia after liver transplant.

Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.

P2888

s12032-013-0625-5

P304

625

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-013-0625-5

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1006424637

http://www.w3.org/2001/XMLSchema#string

P698

23771799

http://www.w3.org/2001/XMLSchema#string

P921